HIV and AIDS News

April 16, 2025

Top Headlines

A New Smartphone-Sized Device Can Test for Tuberculosis: Here's Why That Matters for Children

Apr. 9, 2025 — This handheld device is the first that can detect tuberculosis in saliva, in addition to blood and sputum samples, an important breakthrough for testing children and HIV patients, who struggle to ...

Molecular Stool Test Could Improve Detection of Tuberculosis in Adults With HIV

Apr. 4, 2025 — The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...

Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes

Apr. 2, 2025 — The technology described uses a nanomechanical platform and tiny cantilevers to detect multiple HIV antigens at high sensitivity in a matter of minutes. These silicon cantilevers are cheap and easy to mass produce and can be readily equipped with a ...

New Data on Mpox Vaccine Effectiveness

Mar. 19, 2025 — A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, and people with ...

Latest Headlines

updated 10:48pm EDT

New Understanding of B Cell Mutation Strategies Could Have Implications for Vaccines

Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their best traits instead of rolling the dice and risking deleterious mutations, with ...

Injectable Therapy Is 'Magic' for Those Who Can't Take HIV Pills

Mar. 6, 2025 — Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has ...

Researchers Develop Method to Identify Dormant Cells That Carry HIV

Mar. 13, 2025 — Study findings provide a new gene pathway for potential treatment of the virus affecting ...

Breakthrough CRISPR-Based Test Offers Faster, More Accurate Diagnosis for Fungal Pneumonia

Mar. 3, 2025 — Pneumocystis jirovecii pneumonia (PJP) is the most common fungal pneumonia in children. But current diagnostic methods can take days an require an ...

Stealth Virus: Zika Virus Builds Tunnels to Covertly Infect Cells of the Placenta

Feb. 21, 2025 — Infection with Zika virus in pregnancy can lead to neurological disorders, fetal abnormalities and fetal death. Until now, how the virus manages to ...

New Therapy May Effectively Control HIV in Uganda

Feb. 19, 2025 — A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in ...

Designing Antivirals for Shape-Shifting Viruses

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are ...

Global HIV Study Finds That Cardiovascular Risk Models Underestimate for Key Populations

Jan. 18, 2025 — Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant threat to people with HIV ...

New Study Identifies Key Protein's Role in Psoriasis

Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how ...

A Chain Reaction: HIV Vaccines Can Lead to Antibodies Against Antibodies

Jan. 17, 2025 — Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Tunnel-Building Virus: How Zika Transmits from Mother to Fetus

Mar. 17, 2025 — The Zika virus builds tiny tunnels, called tunneling nanotubes, to stealthily transport material needed to infect nearby cells, including in placental cells, according to a team of researchers from ...

Decoding HIV's Tactics

Jan. 16, 2025 — Scientists have unveiled insights into how HIV-1, the virus responsible for AIDS, skillfully hijacks cellular machinery for its own survival. By dissecting the molecular interplay between the virus ...

Climate Change Linked With Worse HIV Prevention and Care

Jan. 8, 2025 — Researchers analyzed 22 recent studies exploring HIV-related outcomes in the context of climate change and identified several links between extreme weather events and HIV prevention and ...

After Lockdown, Immune System Reacts More Strongly to Viruses and Bacteria

Dec. 18, 2024 — New research shows that the lockdowns during the COVID-19 pandemic had a significant impact on people's immune response to microorganisms. During the lockdown, inflammation level in the body was ...

Study Assesses Virulence of Cryptococcus Strains, Laying Groundwork for Improved Treatment

Dec. 16, 2024 — A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and ...

Updated Hep B Vaccine More Effective for People With HIV

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Clinical Trial Reveals Twice-Yearly Injection to Be 96% Effective in HIV Prevention

Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...

Sub-Saharan Africa Leads Global HIV Decline

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ambitious UNAIDS 2030 ...

HIV Latency Reversing Properties in African Plant

Nov. 19, 2024 — The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African ...

When Hepatitis E Viruses Attack Nerve Cells

Nov. 18, 2024 — Hepatitis E viruses (HEV) typically cause liver infections. They can, however, also infect other organs and cause neurological disorders. Little is yet known about how this process works. A research ...

Probability Training: Preventing Errors of Reasoning in Medicine and Law

Nov. 6, 2024 — A new study shows how students can better understand and interpret conditional ...

Study Demonstrates Efficacy of Iron Supplements for Children Living With HIV

Oct. 31, 2024 — A research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an important first step in optimizing brain ...

Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective, Study Suggests

Oct. 17, 2024 — It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the ...

Promising TB Therapy Appears Safe for Patients With HIV

Oct. 1, 2024 — A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new ...

A Viral Close-Up of HTLV-1

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus, understanding its ...

A Two-Dose Schedule Could Make HIV Vaccines More Effective

Sep. 20, 2024 — Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week ...

Targeted Immune Intervention and Stopping ART in Model of SIV Infection Leads to Control of Viral Replication and Reservoirs

Sep. 12, 2024 — Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV

Sep. 10, 2024 — Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral ...

Potential Link Between DNA Markers and Aging Process

Aug. 19, 2024 — Researchers have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological ...